Life-Saving Drug Combo Lowers Heart and Kidney Risks by 30% 2 min read Endocrinology Life-Saving Drug Combo Lowers Heart and Kidney Risks by 30% Contributor September 25, 2024 This study assesses whether combining glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT-2 inhibitors)... Read More Read more about Life-Saving Drug Combo Lowers Heart and Kidney Risks by 30%